BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 3908575)

  • 1. Immunological potential of a cultivable mycobacterial strain M. habana against leprosy bacillus in mouse foot pad.
    Singh NB; Srivastava ; Gupta HP; Sreevatsa ; Desikan KV
    Indian J Lepr; 1985; 57(2):278-81. PubMed ID: 3908575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae.
    Roche PW; Neupane KD; Failbus SS; Kamath A; Britton WJ
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2):93-8. PubMed ID: 11757171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vaccine from ICRC bacilli against M. leprae infection in mouse foot-pad.
    Bhide MB; Pradhan KS; Bapat CV
    Lepr India; 1978 Jul; 50(3):334-44. PubMed ID: 359922
    [No Abstract]   [Full Text] [Related]  

  • 5. Searches among mycobacterial cultures for antileprosy vaccines.
    Shepard CC; van Landingham R; Walker LL
    Infect Immun; 1980 Sep; 29(3):1034-9. PubMed ID: 7000701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.
    Shepard CC; Van Landingham R; Walker LL
    Infect Immun; 1976 Oct; 14(4):919-28. PubMed ID: 11189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment of viability of M.leprae by mouse foot-pad and fluorescent staining techniques.
    Sreevatsa ; Katoch VM
    Indian J Lepr; 1994; 66(4):455-62. PubMed ID: 7714355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative cross reactivity of habanin, lepromin and tuberculin in guinea pigs sensitized with homologous and heterologous mycobacteria.
    Singh NB; Srivastava A; Gupta HP; Kumar A; Chaturvedi VK
    Indian J Lepr; 1988 Jul; 60(3):407-12. PubMed ID: 3143770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection by live Mycobacterium habana vaccine against Mycobacterium tuberculosis H37Rv challenge in mice.
    Prem Raj P; Srivastava S; Jain SK; Srivastava BS; Srivastava R
    Indian J Med Res; 2003 Apr; 117():139-45. PubMed ID: 14604301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
    Levy L; Ji B
    Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against leprosy].
    Grosset J; Lecoeur H
    Acta Leprol; 1986; 4(3):289-91. PubMed ID: 3551467
    [No Abstract]   [Full Text] [Related]  

  • 15. Effective vaccination of mice against Mycobacterium leprae with density-gradient subfractions of soluble M. leprae proteins: clues to effective protein epitopes.
    Gelber RH; Hunter SW; Murray LP; Siu P; Tsang M; Brennan PJ
    Lepr Rev; 1994 Sep; 65(3):175-80. PubMed ID: 8942148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viability determination of M.leprae: comparison of normal mouse foot pad and bacillary ATP bioluminescence assay.
    Gupta UD; Katoch K; Natarajan M; Sharma VD; Sharma RK; Shivannavar CT; Katoch VM
    Acta Leprol; 1997; 10(4):209-12. PubMed ID: 9447254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
    Janaszek W
    Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective properties of M. lufu in experimental leprosy].
    Iushin MIu; Kalianina OV
    Probl Tuberk; 1995; (2):47-8. PubMed ID: 7777465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ; Meyers WM
    Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of mice against M. leprae infection.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):222-6. PubMed ID: 776860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.